Long Term Beneficial Effects of Weak Electromagnetic Fields in Multiple Sclerosis

References

• Acuna-Castroviejo D., Rosenstein R. E., Romeo H. E., Cardinali D. P. Changes in gamma-aminobutyric acid high affinity binding to cerebral cortex membranes after pinealectomy or melatonin administration to rats. Neuroedocrinology 1986; 43: 24–31
   PubMed Web of Science ®Google Scholar
• Adams R. D., Victor M. Principles of neurology, 3rd Edition. McGraw-Hill Book Company, New York 1985; 699–717
   Google Scholar
• Aldegunde M., Miguez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Angeli A., Gatti G., Sartori M. L., DelPonte D., Garagnola R. Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. The pineal gland and cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, London 1988
   Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Barasi S., Roberts M. H. T. The action of 5-hydroxytryptarnine antagonists and precurson on bulbospinal facilitation of spinal reflexes. Brain Research 1973; 52: 385–388
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Berger J., Sheremata W. Persistent neurological deficit precipitated by hot bath test in MS. Journal of the American Medical Association 1983; 249: 1751–1753
   PubMed Web of Science ®Google Scholar
• Bhaskar P. A., Vanchilingam S., Bhaskar A., Devaprabhu A., Ganesan R. A. Effect of L-dopa on visual evoked potential in patients with Parkinson's disease. Neurology 1986; 36: 1119–1121
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Bodis-Wollner I., Onofrj M. The visual system in Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; 323–327
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Thomton J. Visual evoked potentials and the seventy of Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 126–146
   Google Scholar
• Bodis-Wollner I., Yahr M. D., Mylin L., Thomton J. Dopaminergic deficiency and delayed visual evoked potentials in humans. Annals of Neurology 1982; 11: 478–483
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Broman T. Blood brain barrier damage in multiple sclerosis: supra-vital test observations. Acta Neurologica Scandinavica 1964; 40: 21–24, (Suppl 10)
   PubMed Web of Science ®Google Scholar
• Camegie P. R. Relationship of methylarginine to the main encephalitogenic determinant and some speculative implications for multiple sclerosis. Multiple sclerosis progress in research, E. J. Field, T. M. Bell, P. R. Camegie. North Holland Publishing, Amsterdam 1972; 63–69
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Cutler J. R., Aminoff M. J., Brant-Zawadzki M. Evaluation of patients with multiple sclerosis by evoked potentials and magnetic resonance imaging: a comparative study. Annals of Neurology 1986; 20: 645–648
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Devoino L., Idova G., Alprina E., Cheido M. Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms. Neuroimmune interactions: proceedings of the second international workshop on neuroimmunomodulation, B. D. Jankovic, B. M. Markovic, N. H. Spector. Annals of the New York Academy of Sciences. 1987; 496: 292–300
   Google Scholar
• Dixey R., Rein G. [3H] Noradrenaline release potentiated in aclonal cell line by low intensity pulsed magnetic fields. Nature 1982; 206: 253–256
   Google Scholar
• Dubocovich M. L. Melatonin as a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Ebers G. C. Multiple sclerosis: new insights from old tools. Mayo Clinic Proceedings 1993; 68: 711–712
   PubMed Web of Science ®Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland anatomy. physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994; 343: 271–275
   PubMed Web of Science ®Google Scholar
• Gawel M. J., Das P., Vincent S. Visual and auditory evoked responses in Parkinson's disease. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 138–146
   Google Scholar
• Halliday A. M. Clinical applications of evoked potentials. Recent advances in clinical neurology, W. B. Matthews, G. H. Glaser. Churchill Livingstone, Edinburgh 1978; 47–73
   Google Scholar
• Harrer G., Fischbach R. Uber die wirkung bestimmter aminosauren auf das ergebniss des unbewarmungstests bein multiple sclerose kranken. Journal of Neural Transmission 1973; 34: 205–214
   PubMed Web of Science ®Google Scholar
• Hermann A., Gorman A. L. F. Effects of 4-aminopyridine on potassium currents in a molluscan neuron. Journal of General Physiology 1981; 78: 63–86
   PubMed Web of Science ®Google Scholar
• Holder G. E., Bartlett J. R., Bridges P. K., Kantamanei B. D., Curzon G. Correlation between transmitter metabolite concentrations in human ventricular cerebrospinal fluid and pattern visual evoked potentials. Brain Research 1980; 188: 582–586
   PubMed Web of Science ®Google Scholar
• Hyyppa M. T., Jolma T., Riekkinen P., Rinne C. K. Effects of L-tryptophan on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis. Journal of Neural Transmission 1972; 37: 297–303
   Google Scholar
• Jacobs B. L. Serotonin and behavior: emphasis on motor control. Journal of Clinical Psychiatry 1991; 52: 17–23, (12, suppl)
   PubMed Web of Science ®Google Scholar
• Jacobs B. L. Serotonin, motor activity and depression-related disorders. American Scientist 1994; 82: 456–463
   Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5-HT and motor control: a hypothesis. Trends in Neurosciences 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laczewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioetectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; II: 37–45
   Google Scholar
• Kavaliers M., Hirst M., Teskey G. C. Ageing, opioid analgesia and the pineal gland. Life Sciences 1983; 22: 2279–2287
   Google Scholar
• Kisser W., Harrer G. Amino acid determinations in serum of patients with multiple sclerosis. Wiener Klinische Wochenschrift 1974; 86: 80–82
   PubMed Web of Science ®Google Scholar
• Koella W. P., Czicman J. S. Influence of serotonin upon optic evoked potentials, EEG, and blood pressure of cat. American Journal of Physiology 1963; 204: 873–880
   PubMedGoogle Scholar
• Koopmans R. A., Li D. K. B., Oger J. J. F., Mayo J., Paty D. W. The lesion of multiple sclerosis: imaging of acute and chronic stages. Neurology 1989; 39: 959–963
   PubMed Web of Science ®Google Scholar
• Kumar M. S. A., Chen C. L., Sharp D. C., Liu J. M., Kalra P. S., Kalra S. P. Diurnal fluctuations in methionine-enkephalin levels in the hypothalamus and preoptic area of the male rat: effects of pinealectomy. Neuroendocrinology 1982; 35: 28–31
   PubMed Web of Science ®Google Scholar
• Lakin M. L., Miller C. H., Stott M. L., Winters W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
   PubMed Web of Science ®Google Scholar
• Lennon V. A., Carnegie P. R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1971; 2: 630–633
   Google Scholar
• Luca N., Hategan D. Determination of serotonin content and ceruloplasmin activity of blood and CSF amino acid level in multiple sclerosis. Reveu Roumania Medica Neurologica Psychiatrica 1986; 24: 153–159
   Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987a; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987b; 277–279
   Google Scholar
• Markianos M., Sfagos C. Altered serotonin uptake kinetics in multiple sclerosis. Journal of Neurology 1988; 235: 236–237
   PubMed Web of Science ®Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–441
   PubMed Web of Science ®Google Scholar
• O'Brien D. J., Hughes F. W., Newberne J. Influence of lysergic acid diethylamide on experimental allergic encephalomyelitis. Proceedings of the Society for Experimental Biology 1962; 111: 490–493
   Web of Science ®Google Scholar
• Ossenkopp K. P., Cain D. P. Inhibitory effects of acute exposure to low-intensity 60-Hz magnetic fields on electrically kindled seizures in rats. Brain Research 1988; 442: 255–260
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Neuroimmunomodulation: some recent views and findings. International Journal of Neuroscience 1988; 39: 25–33
   Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis Observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Rao N. A. Chronic experimental allergic optic neuritis. Investigative Ophthalmology and Visual Sciences 1981; 20: 159–172
   PubMed Web of Science ®Google Scholar
• Rascol A., Clanet M., Montastruc J. L., Delage W., Guiraud-Chaumeil B. L-5-hydroxytrophan in the cerebelalr syndrome treatment. Biomedicine 1981; 35: 112–113
   PubMedGoogle Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Reiter R. J. Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation on their implications. Electromagnetic fields and circadian rhythmiciry, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 13–27
   Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, (cell physiol. 31)
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rosenstein R. E., Cardinali D. P. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Research 1986; 398: 403–406
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. D600, a Ca++ antagonist, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992a; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. Magnetic fields stimulate peripheral nerve regeneration in hypophysectomized rats. NeuroReport 1992b; 3: 1039–1041
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M., Mild K. H. The stimulatory effect of magnetic fields on regeneration of the rat sciatic nerve is frequency dependent. Experimental Neurology 1992; 117: 81–84
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994b; 77: 203–227
   PubMed Web of Science ®Google Scholar
• Sandyk R. Chronic relapsing multiple sclerosis: A case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience, in press
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience 1994; 79: 199–212
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995; 81: 215–224
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993b; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994b; 74: 177–189
   PubMedGoogle Scholar
• Schafer E. W. P., McKean C. M. Evidence that monoamines influence human evoked potentials. Brain Research 1975; 99: 49–58
   PubMed Web of Science ®Google Scholar
• Schmidt R. F. Grundriss der neurophysiologie. Springer-Verlag, Berlin 1972; 83–87
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strengh magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–42
   Google Scholar
• Sharma H. S., Dey P. K. Influence of long term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-HT level in conscious normotensive young rats. Journal of Neurological Sciences 1986a; 72: 61–76
   PubMed Web of Science ®Google Scholar
• Sharma H. S., Dey P. K. Probable involvement of 5-hydroxytryptamine in increased permeability of blood brain barrier under heat stress in young rats. Neuropharmacology 1986b; 25: 161–167
   PubMed Web of Science ®Google Scholar
• Sibley W. A. Therapeutic claims in multiple sclerosis. Demos Publications, New York 1992; 15
   Google Scholar
• Sirvio J., Riekkinen P., Jakala P., Riekkinen P. J. Experimental studies on the role of serotonin in cognition. Progress in Neurobiology 1994; 43: 363–379
   PubMed Web of Science ®Google Scholar
• Sokol S. Visual evoked potentials. Electrodiagnosis in clinical neurology, M. J. Aminoff. Churchill Livingstone, New York 1980; 348–369
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Sperber D., Dransfield K., Maret G., Weisenseel M. H. Oriented growth of pollen tubes in strong magnetic field. Naturwissenschaften 1981; 68: 40–43
   Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyin-doleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Trouillas P., Gaval P., Robert J. M., Adeleine P., Jouvet M. Regression de l'ataxie cerebelleuse humaine sous administration a long terme de 5-hydroxytryptophan. C.R. Academie Science (Paris) 1981; 292: 111–119
   Google Scholar
• Van Diemen H. A. M., Polman C. H., Van Dongen M. M. M. M., Nauta J. J. P., Strijers K. L. M., Van Loenen A. C., Bertelsmann F. W., Koetsier J. C. 4-aminopyridine induces functional improvement in multiple sclerosis patients: a neuropsychiological study. Journal of the neurological Sciences 1993; 116: 220–226
   PubMed Web of Science ®Google Scholar
• Wallis D. I. 5-HT receptors involved in initiation or modulation of motor patterns: opportunities for drug development. Trends in Pharmacological Sciences 1994; 15: 288–292
   PubMed Web of Science ®Google Scholar
• Waxman S. G. Clinical course and electrophysiology of multiple sclerosis. Advances in neurology. Functional recovery in neurological disease, S. G. Waxman. Raven Press, New York 1988; Vol. 47: 157–184
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Effects of electromagnetic field exposure on neuroendocrine function. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 29–50
   Google Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis. An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Zeise M. L., Semm P. Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physiology 1985; 157: 23–29
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar